| 中文名称 | 丁基硫 |
| 英文名称 | DL-BUTHIONINE-[S,R]-SULFOXIMINE |
| CAS号 | 5072-26-4 |
| 分子式 | C8H18N2O3S |
| 分子量 | 222.31 |
| EINECS号 | 628-045-7 |
| 熔点 | 215 °C (dec.)(lit.) |
| 沸点 | 382.3±52.0 °C(Predicted) |
| 密度 | 1.29±0.1 g/cm3(Predicted) |
| 溶解度 | H2O:50 mg/mL,澄清,无色 |
| 形态 | 蓬松粉末 |
| 颜色 | 白色 |
| 默克索引编号 | 13,1520 |
| BRN | 2367136 |
| 危险品标志 | Xi |
| 危险类别码 | 36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| RTECS号 | EK7713435 |
| 海关编码 | 29309090 |
| Target | Value |
|
GSH
() |
Buthionine sulfoximine is an analogs of methionine sulfoximine and inhibits gamma-glutamylcysteine synthetase about 20 times more effectively than prothionine sulfoximine and at least 100 times more effectively than methionine sulfoximine.
Treatment of mice bearing HT1080 and HT1080/DR4 xenografts with a continuous i.v infusion of nontoxic doses of D,L-Buthionine-(S,R)-sulfoximine (300 and 600 mg/kg/day) produce a 60% reduction of GSH plasma levels and greater than 95 % reduction in GSH tumor levels in both parental and multidrug-resistant tumors.